Horizon Bioceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 1.73 Cr
as on 16-06-2024
- Company Age 25 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.75 Cr
as on 16-06-2024
- Satisfied Charges ₹ 14.95 Cr
as on 16-06-2024
- Revenue -3.39%
(FY 2023)
- Profit 3.81%
(FY 2023)
- Ebitda 12.11%
(FY 2023)
- Net Worth 18.69%
(FY 2023)
- Total Assets 8.95%
(FY 2023)
About Horizon Bioceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.73 Cr.
The company currently has active open charges totaling ₹40.75 Cr. The company has closed loans amounting to ₹14.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Surinder Sharma, Charanjit Kumar, Mamta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232HR1998PTC034053
- Company No.
034053
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panipat, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Horizon Bioceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surinder Sharma  | Director | 22-Aug-2014 | Current |
| Charanjit Kumar | Director | 10-Mar-2005 | Current |
| Mamta | Director | 16-Oct-1998 | Current |
| Ashok Kumar | Director | 16-Oct-1998 | Current |
| Manoj Garg | Director | 10-Mar-2005 | Current |
Financial Performance and Corporate Structure Insights of Horizon Bioceuticals.
Horizon Bioceuticals Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.39% decrease. The company also saw a slight improvement in profitability, with a 3.81% increase in profit. The company's net worth Soared by an impressive increase of 18.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Horizon Bioceuticals?
In 2023, Horizon Bioceuticals had a promoter holding of 99.89% and a public holding of 0.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Varav Tradex Private Limited
Active
14 years 4 months Charanjit Kumar, Ashok Kumar and 1 more are mutual person
Curewell Limited
Active 10 months 20 days Surinder Sharma, Charanjit Kumar and 3 more are mutual person
Varav Biogenesis Private Limited
Active 14 years 9 months Surinder Sharma, Charanjit Kumar and 3 more are mutual person
Abble Biological Private Limited
Active 8 years 1 month Charanjit Kumar, Ashok Kumar and 1 more are mutual person
Curewell Drugs And Pharmaceuticals Pvt. Ltd.
Active 29 years 6 months Charanjit Kumar, Ashok Kumar and 1 more are mutual person
Cureveda Organic Private Limited
Active 9 years 9 months Charanjit Kumar, Ashok Kumar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Nov 2023 | ₹8.90 Cr | Open |
Others Creation Date: 24 Aug 2023 | ₹6.50 Cr | Open |
Axis Bank Limited Creation Date: 23 May 2022 | ₹1.60 Cr | Open |
How Many Employees Work at Horizon Bioceuticals?
Horizon Bioceuticals has a workforce of 46 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Mar 28, 2014, Horizon Bioceuticals has raised a total of ₹ 5.59 M, with the most recent deal valued at ₹ 1.19 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
